Recruiting studies: Ldl Hyperlipoproteinemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cholesterol Self-testing in Patients Post Acute Coronary Syndrome
NA · 1 location(s) · University of Leipzig · NCT06526013 2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
Phase 2 · 1 location(s) · Vanderbilt University Medical Center · NCT04941599 Mechanism of Ketogenic Diet-Induced Hypercholesterolemia
NA · 1 location(s) · Washington University School of Medicine · NCT06894004 Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Cor
Phase N/A · 13 location(s) · Fondazione SISA (Societa Italiana per lo Studio della Arteri · NCT07447648 Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.
NA · 2 location(s) · Odense University Hospital · NCT05614219 Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterole
Phase 3 · 19 location(s) · Novartis Pharmaceuticals · NCT06597006 Atlantic Lipid Lowering Treatment Optimization Program
NA · 2 location(s) · Atlantic Health System · NCT06439654 Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherap
Phase 4 · 1 location(s) · Dr. Md. Alimur Reza · NCT06789432 Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids
NA · 1 location(s) · Institut de Recherches Cliniques de Montreal · NCT04485871 NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital Xi'an Jiaotong University · NCT06125847 Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Phase 3 · 66 location(s) · Novartis Pharmaceuticals · NCT06597019 Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT02009345 EAS Familial Hypercholesterolaemia Studies Collaboration
Phase N/A · 1 location(s) · Imperial College London · NCT04272697 Early Detection of Familial Hypercholesterolemia in Children
Phase N/A · 2 location(s) · Institut Investigacio Sanitaria Pere Virgili · NCT04370899 Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronar
Phase 3 · 63 location(s) · Novartis Pharmaceuticals · NCT07102628 A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Phase 1 · 24 location(s) · Verve Therapeutics, Inc. · NCT06164730 A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
Phase 3 · 18 location(s) · Hasten Biopharmaceutical Co., Ltd. · NCT06568471

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.